Company intelligence / Profile preview
Mikrobiomik
Derio, Basque Country, Spainmikrobiomik.net ↗
- Ownership
- Private
- Employees
- ~21
- Development stage
- Phase 3
01
Overview
Mikrobiomik has completed a Phase III clinical trial for its lead product MBK‐01, an oral capsule containing full-spectrum purified intestinal microbiota for the treatment of Clostridioides difficile infections. The company claims it will be the first to market a gut microbiota-based biologic in the EU. Additional programs are underway targeting MASH, acute uncomplicated diverticulitis, and metastatic colorectal cancer at earlier stages.
- Therapeutic areas
- Metabolic DisordersOncologyGastroenterologyInfectious Diseases
- Modalities
- Microbiome-based biologics (specifically full-spectrum and purified intestinal microbiota)Lyophilized oral capsules of fecal microbiota
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
In discussions with several pharmaceutical companies regarding licensing/commercialization agreements for MBK‐01
Beyond the preview
Go deeper on Mikrobiomik.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mikrobiomik.